imPORTND Patient-Oriented Research Training for Neuromuscular Disease Seeks Research Teams for Testing

The NMD4C is excited to introduce our online training platform “imPORTND”, created to help scientists engage with patient partners in research. These modules are designed for all neuromuscular research team members including researchers, staff, and patient partners.

imPORTND has been co-developed with a team of expert patient partners, clinicians, and researchers, and offer two modules to help scientists engage with patient partners in research. It is the first patient-oriented research training that focuses specifically on neuromuscular disease.

Acknowledging that all research participants come with different experiences and knowledge, the training platform is designed for users to decide what their own and their team learning needs are, and to select those activities which will be most helpful.

The NMD4C is seeking research teams to test the first two modules of the training platform before it fully launches later this fall. Please contact Patricia Mortenson or James Davis at or to sign up!

imPORTND - soft launch image

Read next...

NEWS Website Featured Images

Call for Applications: Join the NMD4C Basic Science Trainee Committee (BSTC)

We are now accepting applications from graduate students, research trainees, and postdoctoral fellows working in neuromuscular labs in Canada.

NMD4C's BSTC launches SOP database

Basic Science Trainee Committee Launches Pre-Clinical Science Standard Operating Procedures

We’re pleased to announce the launch of the BSTC Standard Operating Procedures (SOPs), now available through the NMD4C Resource Hub. These SOPs provide standardized guidance for laboratories, clinics, and research programs across Canada, supporting consistent, high-quality neuromuscular care and research. Explore the full SOP Library and other open-access resources designed to advance collaboration and strengthen practices nationwide.

Hope On The Horizon: Trials Treatments and Therapies for DMD, DM1 and MG

Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG

Nov 26-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!